PLEKHA7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.608200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.316800E-01
Normal-vs-Stage2
3.823800E-01
Normal-vs-Stage3
8.709600E-01
Normal-vs-Stage4
4.711800E-01
Stage1-vs-Stage2
2.649000E-01
Stage1-vs-Stage3
7.347000E-01
Stage1-vs-Stage4
3.324800E-01
Stage2-vs-Stage3
2.076400E-01
Stage2-vs-Stage4
9.348000E-01
Stage3-vs-Stage4
3.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.689600E-01
Normal-vs-AfricanAmerican
9.664800E-01
Normal-vs-Asian
5.857000E-01
Caucasian-vs-AfricanAmerican
3.303400E-01
Caucasian-vs-Asian
7.761000E-01
AfricanAmerican-vs-Asian
4.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.654200E-01
Normal-vs-Female
6.407800E-01
Male-vs-Female
1.872320E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.311800E-01
Normal-vs-Age(41-60Yrs)
3.406200E-01
Normal-vs-Age(61-80Yrs)
5.589400E-01
Normal-vs-Age(81-100Yrs)
5.200000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.197600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.585800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.272400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.975700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.200000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.424600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.244000E-01
Normal-vs-Daily Drinker
5.604800E-01
Normal-vs-Weekly Drinker
9.670600E-01
Normal-vs-Occasional Drinker
2.981400E-01
Normal-vs-Social Drinker
6.447200E-01
Non Drinker-vs-Daily Drinker
5.531400E-01
Non Drinker-vs-Weekly Drinker
1.631760E-01
Non Drinker-vs-Occasional Drinker
3.907200E-01
Non Drinker-vs-Social Drinker
3.358400E-01
Daily Drinker-vs-Weekly Drinker
3.549200E-01
Daily Drinker-vs-Occasional Drinker
1.868190E-01
Daily Drinker-vs-Social Drinker
6.679000E-01
Weekly Drinker-vs-Occasional Drinker
6.919600E-02
Weekly Drinker-vs-Social Drinker
5.632000E-01
Occasional Drinker-vs-Social Drinker
9.761900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.070960E-01
Normal-vs-Grade 2
2.519800E-02
Normal-vs-Grade 3
9.718200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.204900E-04
Grade 1-vs-Grade 3
1.32070000002926E-06
Grade 1-vs-Grade 4
1.070960E-01
Grade 2-vs-Grade 3
1.107550E-02
Grade 2-vs-Grade 4
2.519800E-02
Grade 3-vs-Grade 4
9.718200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.674600E-01
Normal-vs-NonDiabetic
4.508400E-01
Diabetic-vs-NonDiabetic
2.050000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.686200E-01
Normal-vs-NoPancreatitis
5.024200E-01
Pancreatitis-vs-NoPancreatitis
4.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.989800E-01
Normal-vs-N1
4.141400E-01
N0-vs-N1
5.587400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.818400E-02
Normal-vs-TP53-NonMutant
6.138600E-01
TP53-Mutant-vs-TP53-NonMutant
2.26799999999416E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
